BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12115728)

  • 1. Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression.
    Lamb D; Steinberg RA
    J Cell Physiol; 2002 Aug; 192(2):216-24. PubMed ID: 12115728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8-Chloroadenosine mediates 8-chloro-cyclic AMP-induced down-regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP-independent mechanism.
    Lange-Carter CA; Vuillequez JJ; Malkinson AM
    Cancer Res; 1993 Jan; 53(2):393-400. PubMed ID: 8380255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8-chloroadenosine 3',5'-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts.
    Noguchi K; Murata T; Cho-Chung YS
    Eur J Cancer; 1998 Jul; 34(8):1260-7. PubMed ID: 9849489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-Chloro-cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells.
    Ahn YH; Jung JM; Hong SH
    Cancer Res; 2005 Jun; 65(11):4896-901. PubMed ID: 15930311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells.
    Gandhi V; Ayres M; Halgren RG; Krett NL; Newman RA; Rosen ST
    Cancer Res; 2001 Jul; 61(14):5474-9. PubMed ID: 11454694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cAMP analogs have potent anti-proliferative effects on medullary thyroid cancer cell lines.
    Dicitore A; Grassi ES; Caraglia M; Borghi MO; Gaudenzi G; Hofland LJ; Persani L; Vitale G
    Endocrine; 2016 Jan; 51(1):101-12. PubMed ID: 25863490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Cl-cAMP and its metabolite, 8-Cl-adenosine induce growth inhibition in mouse fibroblast DT cells through the same pathways: protein kinase C activation and cyclin B down-regulation.
    Ahn YH; Jung JM; Hong SH
    J Cell Physiol; 2004 Nov; 201(2):277-85. PubMed ID: 15334662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation of nontransformed cells is inhibited by adenosine metabolite of but not by parental 8-Cl-cyclic AMP.
    Han Z; Chatterjee D; Wyche JH
    J Pharmacol Exp Ther; 1993 May; 265(2):790-4. PubMed ID: 8388460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase A-independent inhibition of proliferation and induction of apoptosis in human thyroid cancer cells by 8-Cl-adenosine.
    Robinson-White AJ; Hsiao HP; Leitner WW; Greene E; Bauer A; Krett NL; Nesterova M; Stratakis CA
    J Clin Endocrinol Metab; 2008 Mar; 93(3):1020-9. PubMed ID: 18073299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanisms.
    Lucchi S; Calebiro D; de Filippis T; Grassi ES; Borghi MO; Persani L
    PLoS One; 2011; 6(6):e20785. PubMed ID: 21695205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of type II regulatory subunit of cAMP-dependent protein kinase in human cisplatin-resistant cells as a basis of collateral sensitivity to 8-chloro-cAMP.
    Nishio K; Morikage T; Kubota N; Ohmori T; Takeda Y; Fujiwara Y; Miki K; Abe K; Saijo N
    Jpn J Cancer Res; 1992 Jul; 83(7):754-60. PubMed ID: 1325432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of human glioma cells induced by 8-chloroadenosine, an active metabolite of 8-chloro cyclic adenosine 3':5'-monophosphate.
    Langeveld CH; Jongenelen CA; Heimans JJ; Stoof JC
    Cancer Res; 1992 Jul; 52(14):3994-9. PubMed ID: 1617676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of colon tumor cell growth by 8-chloro-cAMP is dependent upon its conversion to 8-chloro-adenosine.
    Taylor CW; Yeoman LC
    Anticancer Drugs; 1992 Oct; 3(5):485-91. PubMed ID: 1450443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide expression profiling of 8-chloroadenosine- and 8-chloro-cAMP-treated human neuroblastoma cells using radioactive human cDNA microarray.
    Park GH; Choe J; Choo HJ; Park YG; Sohn J; Kim MK
    Exp Mol Med; 2002 Jul; 34(3):184-93. PubMed ID: 12216110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of oocyte maturation and cumulus expansion in the mouse oocyte-cumulus cell complex by site-selective analogs of cyclic adenosine monophosphate.
    Downs SM; Hunzicker-Dunn M
    Dev Biol; 1995 Nov; 172(1):72-85. PubMed ID: 7589815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiproliferative effect of 8-chloro-adenosine, an active metabolite of 8-chloro-cyclic adenosine monophosphate, and disturbances in nucleic acid synthesis and cell cycle kinetics.
    Langeveld CH; Jongenelen CA; Theeuwes JW; Baak JP; Heimans JJ; Stoof JC; Peters GJ
    Biochem Pharmacol; 1997 Jan; 53(2):141-8. PubMed ID: 9037246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-Cl-adenosine is an active metabolite of 8-Cl-cAMP responsible for its in vitro antiproliferative effects on CHO mutants hypersensitive to cytostatic drugs.
    Robbins SK; Houlbrook S; Priddle JD; Harris AL
    Cancer Chemother Pharmacol; 2001 Dec; 48(6):451-8. PubMed ID: 11800025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 8-chloro-cyclic adenosine monophosphate on the growth and sensitivity to doxorubicin of multidrug-resistant tumour cell lines.
    Borsellino N; Crescimanno M; Leonardi V; D'Alessandro N
    Pharmacol Res; 1994 Jul; 30(1):81-90. PubMed ID: 7831198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-Cl-adenosine-induced inhibition of colorectal cancer growth in vitro and in vivo.
    Carlson CC; Chinery R; Burnham LL; Dransfield DT
    Neoplasia; 2000; 2(5):441-8. PubMed ID: 11191111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.
    Rohlff C; Safa B; Rahman A; Cho-Chung YS; Klecker RW; Glazer RI
    Mol Pharmacol; 1993 Mar; 43(3):372-9. PubMed ID: 8383802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.